Similarly, the strategic oral administration of Salmonella enterica in the context of lung cancer therapies specifically targeting VEGFR-3 serves as a notable example of the inventive implementation of nucleic acid-based vaccines [114]. The gene discussed is FLT4; the disease is lung cancer.